Tadeusz Robak

Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial

2018 | Ústřední knihovna, Lékařská fakulta v Plzni

Publikace